Dopamine transporter, but not tyrosine hydroxylase, may be implicated in determining individual differences in behavioral sensitization to amphetamine

Physiology and Behavior

Volumn 86, Issue 3, 2005, Pages 347-355

  Dietz, David M ^a,b   Tapocik, Jenica ^a   Gaval Cruz, Meriem ^a   Kabbaj, Mohamed ^a,b  

^a FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b FLORIDA STATE UNIVERSITY   (United States)

Author keywords

Amphetamine; Behavioral sensitization; Brain; Dopamine; Dopamine transporter; HR LR; In situ hybridization; Individual differences; Locomotor reactivity; mRNA; Psychostimulants; Rat; Sprague Dawley; Substantia nigra; Tyrosine hydroxylase; Ventral tegmental area

Indexed keywords

AMPHETAMINE; DOPAMINE TRANSPORTER; MESSENGER RNA; SODIUM CHLORIDE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SENSITIZATION; DRUG WITHDRAWAL; INJECTION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECORDING; SUBSTANTIA NIGRA; UPREGULATION; VENTRAL TEGMENTUM;

EID: 26944500129     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2005.08.005     Document Type: Article

References (46)

1. T.E. Robinson, and J.B. Becker Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis Brain Res 396 2 1986 157 198
2. R.A. Wise, and M.A. Bozarth A psychomotor stimulant theory of addiction Psychol Rev 94 4 1987 469 492
3. P.W. Kalivas, and J. Stewart Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity Brain Res Rev 16 3 1991 223 244
4. D.S. Segal, and R. Kuczenski Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens Brain Res 577 2 1992 351 355
5. P.E. Paulson, and T.E. Robinson Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats Synapse 19 1 1995 56 65
6. Y.L. Hurd, F. Weiss, G.F. Koob, N.-E. And, and U. Ungerstedt Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbens: an in vivo microdialysis study*1 Brain Res 498 1 1989 199 203
7. D.S. Segal, and R. Kuczenski In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment Brain Res 571 2 1992 330 337
8. B. Giros, and M.G. Caron Molecular characterization of the dopamine transporter Trends Pharmacol Sci 14 2 1993 43 49
9. J.F. Fischer, and A.K. Cho Chemical release of dopamine from striatal homogenates evidence for an exchange diffusion model J Pharmacol Exp Ther 208 2 1979 203 209
10. D. Sulzer, N.T. Maidment, and S. Rayport Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons J Neurochem 60 2 1993 527 535
11. R.C. Pierce, and P.W. Kalivas A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants Brain Res Brain Res Rev 25 2 1997 192 216
12. A.N. Mead, B.A. Rocha, D.M. Donovan, and J.L. Katz Intravenous cocaine induced-activity and behavioural sensitization in norepinephrine-, but not dopamine-transporter knockout mice Eur J Neurosci 16 3 2002 514 520
13. P.D. Shilling, J.R. Kelsoe, and D.S. Segal Dopamine transporter mRNA is up-regulated in the substantia nigra and the ventral tegmental area of amphetamine-sensitized rats Neurosci Lett 236 3 1997 131 134
14. Y.L. Hurd, N. Lindefors, E. Brodin, S. Brene, H. Persson, and U. Ungerstedt Amphetamine regulation of mesolimbic dopamine/cholecystokinin neurotransmission Brain Res 578 1-2 1992 317 326
15. D. Alvarez Fischer, M.K. Schafer, B. Ferger, S. Gross, R. Westermann, and E. Weihe Sensitization to the behavioural effects of cocaine: alterations in tyrosine hydroxylase or endogenous opioid mRNAs are not necessarily involved Naunyn Schmiedebergs Arch Pharmacol 363 3 2001 288 294
16. M.S. Todtenkopf, K.R. De Leon, and J.R. Stellar Repeated cocaine treatment alters tyrosine hydroxylase in the rat nucleus accumbens Brain Res Bull 52 5 2000 407 411
17. B.A. Sorg, S.Y. Chen, and P.W. Kalivas Time course of tyrosine hydroxylase expression after behavioral sensitization to cocaine J Pharmacol Exp Ther 266 1 1993 424 430
18. J.M. Deminiere, P.V. Piazza, M. Le Moal, and H. Simon Experimental approach to individual vulnerability to psychostimulant addiction Neurosci Biobehav Rev 13 2-3 1989 141 147
19. P.V. Piazza, J.M. Deminiere, M. Le Moal, and H. Simon Factors that predict individual vulnerability to amphetamine self-administration Science 245 4925 1989 1511 1513
20. M.S. Hooks, G.H. Jones, A.D. Smith, D.B. Neill, and J.B. Justice Jr. Response to novelty predicts the locomotor and nucleus accumbens dopamine response to cocaine Synapse 9 2 1991 121 128
21. M.S. Hooks, G.H. Jones, D.B. Neill, and J.B. Justice Jr. Individual differences in amphetamine sensitization: dose-dependent effects Pharmacol Biochem Behav 41 1 1992 203 210
22. M. Kabbaj, C.S. Norton, S. Kollack-Walker, S.J. Watson, T.E. Robinson, and H. Akil Social defeat alters the acquisition of cocaine self-administration in rats: role of individual differences in cocaine-taking behavior Psychopharmacology (Berl) 158 4 2001 382 387
23. M.S. Hooks, A.C. Colvin, J.L. Juncos, and J.B. Justice Jr. Individual differences in basal and cocaine-stimulated extracellular dopamine in the nucleus accumbens using quantitative microdialysis Brain Res 587 2 1992 306 312
24. M.S. Hooks, B.A. Sorg, and P.W. Kalivas The relationship between MRNA levels and the locomotor response to novelty Brain Res 663 2 1994 312 316
25. L.R. Lucas, J.A. Angulo, M. Le Moal, B.S. McEwen, and P.V. Piazza Neurochemical characterization of individual vulnerability to addictive drugs in rats Eur J Neurosci 10 10 1998 3153 3163
26. V.I. Chefer, I. Zakharova, and T.S. Shippenberg Enhanced responsiveness to novelty and cocaine is associated with decreased basal dopamine uptake and release in the nucleus accumbens: quantitative microdialysis in rats under transient conditions J Neurosci 23 7 2003 3076 3084
27. M.S. Hooks, G.H. Jones, A.D. Smith, D.B. Neill, and J.B. Justice Jr. Individual differences in locomotor activity and sensitization Pharmacol Biochem Behav 38 2 1991 467 470
28. B. Giros, M. Jaber, S.R. Jones, R.M. Wightman, and M.G. Caron Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter Nature 379 6566 1996 606 612
29. W. Lu, and M.E. Wolf Expression of dopamine transporter and vesicular monoamine transporter 2 mRNAs in rat midbrain after repeated amphetamine administration Brain Res Mol Brain Res 49 1-2 1997 137 148
30. A.M. Persico, C.W. Schindler, M.T. Brannock, A.M. Gonzalez, C.K. Surratt, and G.R. Uhl Dopaminergic gene expression during amphetamine withdrawal Neuroreport 4 1 1993 41 44
31. J.E. Kilty, D. Lorang, and S.G. Amara Cloning and expression of a cocaine-sensitive rat dopamine transporter Science 254 5031 1991 578 579
32. S.R. Jones, R.R. Gainetdinov, R.M. Wightman, and M.G. Caron Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter J Neurosci 18 6 1998 1979 1986
33. R.C. Pierce, and P.W. Kalivas Repeated cocaine modifies the mechanism by which amphetamine releases dopamine J Neurosci 17 9 1997 3254 3261
34. T.Z. Shaw-Lutchman, S. Impey, D. Storm, and E.J. Nestler Regulation of CRE-mediated transcription in mouse brain by amphetamine Synapse 48 1 2003 10 17
35. S.M. Yatin, G.M. Miller, C. Norton, and B.K. Madras Dopamine transporter-dependent induction of C-Fos in HEK cells Synapse 45 1 2002 52 65
36. J.F. McGinty Regulation of neurotransmitter interactions in the ventral striatum Ann N Y Acad Sci 877 1999 129 139
37. P. Sacchetti, L.A. Brownschidle, J.G. Granneman, and M.J. Bannon Characterization of the 5′-flanking region of the human dopamine transporter gene Brain Res Mol Brain Res 74 1-2 1999 167 174
38. R.A. Vaughan, R.A. Huff, G.R. Uhl, and M.J. Kuhar Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes J Biol Chem 272 24 1997 15541 15546
39. M. Batchelor, and J.O. Schenk Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine J Neurosci 18 24 1998 10304 10309
40. M.S. Hooks, J.L. Juncos, J.B. Justice Jr., S.M. Meiergerd, S.L. Povlock, and J.O. Schenk Individual locomotor response to novelty predicts selective alterations in D1 and D2 receptors and mRNAs J Neurosci 14 10 1994 6144 6152
41. M.J.D. Miserendino, X. Guitart, R.Z. Terwilliger, S. Chi, and E.J. Nestler Individual differences in locomotor activity are associated with levels of tyrosine hydroxylase and neurofilament proteins in the ventral tegmental area of Sprague-Dawley rats Mol Cell Neurosci 4 5 1993 440 448
42. P.W. Kalivas Neurotransmitter regulation of dopamine neurons in the ventral tegmental area Brain Res Brain Res Rev 18 1 1993 75 113
43. S.L. Vrana, K.E. Vrana, T.R. Koves, J.E. Smith, and S.I. Dworkin Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels J Neurochem 61 6 1993 2262 2268
44. D. Beitner-Johnson, and E.J. Nestler Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions J Neurochem 57 1 1991 344 347
45. C.C. Ouimet, P.E. Miller, H.C. Hemmings Jr., S.I. Walaas, and P. Greengard DARPP-32, a dopamine- and adenosine 3′ : 5′-monophosphate- regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization J Neurosci 4 1 1984 111 124
46. M.M. Ostrander, A. Badiani, H.E. Day, C.S. Norton, S.J. Watson, and H. Akil Environmental context and drug history modulate amphetamine-induced c-fos mRNA expression in the basal ganglia, central extended amygdala, and associated limbic forebrain Neuroscience 120 2 2003 551 571